Cyclopharm News

Cyclopharm Lodges NDA for Technegas® with the USFDA

30th Mar 2020

Continue Reading

Technegas™ is not an aerosol generating procedure

23rd Mar 2020

Continue Reading

Technegas™ and Covid-19

20th Mar 2020

Continue Reading

TechKnow Invest Roadshow

21st Oct 2019

Continue Reading

Cyclomedica will exhibit at the ANZSNM 2019 Annual Scientific Meeting

15th Apr 2019

Continue Reading

Cyclomedica will exhibit at the German Annual Meeting of Nuclear Medicine

1st Mar 2019

Continue Reading

Cyclomedica will exhibit at the EANM 2019 congress

1st Mar 2019

Continue Reading

New Guidelines from the Canadian Association of Nuclear Medicine

21st Dec 2018

Continue Reading

Cyclopharm (ASX:CYC) results of US FDA meeting

29th Oct 2018

Continue Reading

Cyclopharm (ASX:CYC) radiopharmaceutical leader

3rd Oct 2018

Continue Reading

Our 4th million Patient Administration Set has been manufactured

31st May 2018

Continue Reading

New clinical trial to develop better tools for asthma and COPD

18th May 2018

Continue Reading

First 40 patients’ milestone reached in USFDA Phase 3 Technegas study

29th Mar 2018

Continue Reading

Cyclopharm (ASX.CYC) Presentation, FNN Investor Event, Dec 2017, Sydney

20th Dec 2017

Continue Reading

CEO & MD, James McBrayer talks lung disease screening

19th Dec 2017

Continue Reading

Copyright © Cyclopharm 2020 | Last Updated: March 8, 2019 Privacy Policy